The validity of nasal endoscopy in patients with chronic rhinosinusitis—An inter‐rater agreement study

Larsen, K.; Lange, Bibi; Darling, Peter; Jørgensen, Gita; Kjeldsen, Anette Drøhse

doi:10.1111/coa.12916

Cited by 9 publications

(11 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Inter‐rater and test‐retest reliability varies depending on the domain assessed (polyp, discharge, crusting, etc.) and the specific scoring system 258 . These endoscopic scoring systems typically correlate only weakly with QoL measures 259,260 .…”

Section: General Concepts Of Rhinosinusitismentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

518

479

View full text Add to dashboard Cite

I. Executive Summary Background The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.

show abstract

Section: General Concepts Of Rhinosinusitismentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

518

479

View full text Add to dashboard Cite

show abstract

“…While other studies have attempted to identify a specific measurement that constitutes a normal IAMH, there is a lack of sufficient evidence to correlate these measurements to a clinical phenotype. 5,14,15 The IAAP specifically delineates IAMHs above the traditional T1C but includes IAMHs at and below the level of the true vocal folds, which is the current working definition we are using at our institution for a T1C. Future studies that use the IAAP would allow for more accurate comparisons of the IAMH and other independent variables to clinical outcomes, and ultimately a clinically relevant definition for laryngeal cleft could potentially be further refined from our current working definition.…”

Section: Discussionmentioning

confidence: 99%

Standardizing Laryngeal Cleft Evaluations: Reliability of the Interarytenoid Assessment Protocol

Coppess

Padia

Horn

et al. 2018

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

Objective While the Benjamin-Inglis classification system is widely used to categorize laryngeal clefts, it does not clearly differentiate a type 1 cleft from normal anatomy, and there is no widely accepted or validated protocol for systematically evaluating interarytenoid mucosal height. We sought to propose the interarytenoid assessment protocol as a method to standardize the description of the interarytenoid anatomy and to test its reliability. Study Design Retrospective review of endoscopic videos. Setting Pediatric academic center. Subjects and Methods The interarytenoid assessment protocol comprises 4 steps for evaluation of the interarytenoid region relative to known anatomic landmarks in the supraglottis, glottis, and subglottis. Thirty consecutively selected videos of the protocol were reviewed by 4 otolaryngologists. The raters were blinded to identifying information, and the video order was randomized for each review. We assessed protocol completion times and calculated Cohen’s linear-weighted κ coefficient between blinded expert raters and with the operating surgeon to evaluate interrater/intrarater reliability. Results Median age was 4.9 years (59 months; range, 1 month to 20 years). Median completion time was 144 seconds. Interrater and intrarater reliability showed substantial agreement (interrater κ = 0.71 [95% confidence interval (CI), 0.55-0.87]; intrarater mean κ = 0.70 [95% CI, 0.59-0.92/rater 1, 0.47-0.85/rater 2]; P < .001). Comparing raters to the operating surgeon demonstrated substantial agreement (mean κ = 0.62; 95% CI, 0.31-0.79/rater 1, 0.48-0.89/rater 2; P < .001). Conclusion The interarytenoid assessment protocol appears reliable in describing interarytenoid anatomy. Rapid completion times and substantial interrater/intrarater reliability were demonstrated. Incorporation of this protocol may provide important steps toward improved standardization in the anatomic description of the interarytenoid region in pediatric dysphagia.

show abstract

“…At enrollment, the presence of comorbid asthma was determined based on guideline criteria, 25 and aeroallergen hypersensitivity was determined based on skin or serological testing. The presence of polyps was determined based on nasal endoscopy by the treating rhinologist 26 . All participants completed the 22‐item Sino‐Nasal Outcome Test (SNOT‐22) to measure CRS symptom burden 27 .…”

Section: Methodsmentioning

confidence: 99%

“…The presence of polyps was determined based on nasal endoscopy by the treating rhinologist. 26 All participants completed the 22-item Sino-Nasal Outcome Test (SNOT-22) to measure CRS symptom burden. 27 We used a pragmatic design with respect to assessing CRS-related antibiotics and oral corticosteroids.…”

Section: Study Design and Data Collectionmentioning

confidence: 99%

Appropriate medical management of chronic rhinosinusitis reduces use of antibiotics and oral corticosteroids

et al. 2019

View full text Add to dashboard Cite

Objectives/Hypothesis: Antibiotics and oral corticosteroids are used in the treatment of acute exacerbations of chronic rhinosinusitis (AECRS) and reflect poor disease control. We sought to characterize utilization of these systemic medications after appropriate medical management of chronic rhinosinusitis (CRS). Study Design: Prospective observational study. Methods: One hundred fifty patients undergoing medical management for CRS were studied. Data were collected at enrollment and follow-up 3 to 12 months later. All patients were asked to report the number of CRS-related antibiotics and oral corticosteroids used in the last 3 months. CRS symptom burden was measured using the 22-item Sino-Nasal Outcome Test (SNOT-22). Associations were sought between CRS-related antibiotics and oral corticosteroids use at follow-up compared to enrollment. Results: From enrollment to follow-up, the mean number of CRS-related antibiotics courses used decreased by 0.2 courses (95% confidence interval [CI]: 0.1-0.4, P = .012), and the mean number of CRS-related oral corticosteroid courses used also decreased by 0.2 courses (95% CI: 0.1-0.3, P = .029). The number of CRS-related antibiotics used at follow-up was associated with CRS-related antibiotic use at enrollment (adjusted rate ratio [RR] = 1.58, 95% CI: 1.17-2.13, P = .003). The number of CRS-related oral corticosteroids used at follow-up was associated with reported CRS-related oral corticosteroid use at enrollment (adjusted RR = 3.20, 95% CI: 1.69-6.07, P < .001). SNOT-22 results at enrollment were also not predictive of future systemic medication use. Conclusions: Appropriate medical management of CRS is associated with decreased use of oral antibiotics and corticosteroids. Previous utilization of antibiotics and oral corticosteroids for CRS is associated with future use of these medications.

show abstract

The validity of nasal endoscopy in patients with chronic rhinosinusitis—An inter‐rater agreement study

Cited by 9 publications

References 16 publications

International consensus statement on allergy and rhinology: rhinosinusitis 2021

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Standardizing Laryngeal Cleft Evaluations: Reliability of the Interarytenoid Assessment Protocol

Appropriate medical management of chronic rhinosinusitis reduces use of antibiotics and oral corticosteroids

Contact Info

Product

Resources

About